Emergent BioSolutions Highlights Biodefense Role Amid Evolving Threats

Emergent BioSolutions underscored the growing importance of biological threat preparedness amidst an evolving security environment, citing risks from AI, synthetic biology, and geopolitical conflicts. The company highlighted its 25 years of partnering with governments to address potential bioterrorism threats and ensure robust response capabilities. Emergent also referenced a new NEJM Evidence study reinforcing the importance of its CYFENDUS® vaccine for anthrax post-exposure prophylaxis, reaffirming its commitment to collaborating on safeguards against emerging biological threats.